BACKGROUND: The current study was performed to evaluate risk factors for severe coronavirus disease 2019 (COVID-19) outcomes among Medicare beneficiaries during the pandemic's early phase. METHODS: In a retrospective cohort study covering Medicare fee-for-service beneficiaries, we separated out elderly residents in nursing homes (NHs) and those with end-stage renal disease (ESRD) from the primary study population of individuals age ≥65 years. Outcomes included COVID-19 hospital encounters and COVID-19-associated deaths. We estimated adjusted odds ratios (ORs) using logistic regression. RESULTS: We analyzed 25 333 329 elderly non-NH beneficiaries without ESRD, 653 966 elderly NH residents, and 292 302 patients with ESRD. COVID-related death rates (per 10 000) were much higher among elderly NH residents (275.7) and patients with ESRD (60.8) than in the primary study population (5.0). Regression-adjusted clinical predictors of death among the primary population included immunocompromised status (OR, 1.43), frailty index conditions such as cognitive impairment (3.16), and other comorbid conditions, including congestive heart failure (1.30). Demographic-related risk factors included male sex (OR, 1.77), older age (3.09 for 80- vs 65-year-olds), Medicaid dual-eligibility status (2.17), and racial/ethnic minority. Compared with whites, ORs were higher for blacks (2.47), Hispanics (3.11), and Native Americans (5.82). Results for COVID-19 hospital encounters were consistent. CONCLUSIONS: Frailty, comorbid conditions, and race/ethnicity were strong risk factors for COVID-19 hospitalization and death among the US elderly. Published by Oxford University Press for the Infectious Diseases Society of America 2020.
BACKGROUND: The current study was performed to evaluate risk factors for severe coronavirus disease 2019 (COVID-19) outcomes among Medicare beneficiaries during the pandemic's early phase. METHODS: In a retrospective cohort study covering Medicare fee-for-service beneficiaries, we separated out elderly residents in nursing homes (NHs) and those with end-stage renal disease (ESRD) from the primary study population of individuals age ≥65 years. Outcomes included COVID-19 hospital encounters and COVID-19-associated deaths. We estimated adjusted odds ratios (ORs) using logistic regression. RESULTS: We analyzed 25 333 329 elderly non-NH beneficiaries without ESRD, 653 966 elderly NH residents, and 292 302 patients with ESRD. COVID-related death rates (per 10 000) were much higher among elderly NH residents (275.7) and patients with ESRD (60.8) than in the primary study population (5.0). Regression-adjusted clinical predictors of death among the primary population included immunocompromised status (OR, 1.43), frailty index conditions such as cognitive impairment (3.16), and other comorbid conditions, including congestive heart failure (1.30). Demographic-related risk factors included male sex (OR, 1.77), older age (3.09 for 80- vs 65-year-olds), Medicaid dual-eligibility status (2.17), and racial/ethnic minority. Compared with whites, ORs were higher for blacks (2.47), Hispanics (3.11), and Native Americans (5.82). Results for COVID-19 hospital encounters were consistent. CONCLUSIONS: Frailty, comorbid conditions, and race/ethnicity were strong risk factors for COVID-19 hospitalization and death among the US elderly. Published by Oxford University Press for the Infectious Diseases Society of America 2020.
Authors: Sheryl Zimmerman; Carol Dumond-Stryker; Meera Tandan; John S Preisser; Christopher J Wretman; Abigail Howell; Susan Ryan Journal: J Am Med Dir Assoc Date: 2021-01-26 Impact factor: 4.669
Authors: Fàtima Crispi; Francesca Crovetto; Alvar Agustí; Eduard Gratacós; Marta Larroya; Marta Camacho; Marta Tortajada; Oriol Sibila; Joan Ramon Badia; Marta López; Kilian Vellvé; Ferran Garcia; Antoni Trilla; Rosa Faner; Isabel Blanco; Roger Borràs Journal: Sci Rep Date: 2021-02-03 Impact factor: 4.379
Authors: Kamal Abu Jabal; Hila Ben-Amram; Karine Beiruti; Yunis Batheesh; Christian Sussan; Salman Zarka; Michael Edelstein Journal: Euro Surveill Date: 2021-02
Authors: Felicia Ceban; Danica Nogo; Isidro P Carvalho; Yena Lee; Flora Nasri; Jiaqi Xiong; Leanna M W Lui; Mehala Subramaniapillai; Hartej Gill; Rene N Liu; Prianca Joseph; Kayla M Teopiz; Bing Cao; Rodrigo B Mansur; Kangguang Lin; Joshua D Rosenblat; Roger C Ho; Roger S McIntyre Journal: JAMA Psychiatry Date: 2021-10-01 Impact factor: 25.911
Authors: A Padilha de Lima; M Macedo Rogero; T Araujo Viel; H M Garay-Malpartida; I Aprahamian; S M Lima Ribeiro Journal: J Nutr Health Aging Date: 2022 Impact factor: 5.285
Authors: João Locke Ferreira de Araújo; Diego Menezes; Julia Maria Saraiva-Duarte; Luciana de Lima Ferreira; Renato Santana de Aguiar; Renan Pedra de Souza Journal: Rev Med Virol Date: 2021-08-02 Impact factor: 11.043